Taiwan FDA registration b52f814c0f937d0ea65c0cec659adcf3
In vitro reagent for Genor pregnancy test
TW: 嘉和驗孕體外試劑
Taiwan·Risk Class 2·Longteng Biotechnology Co., Ltd. Xinshi Factory;; Genor Biotechnology Co., Ltd·Registered Aug 12, 2019 – Oct 26, 2028ActiveRegistration details
- Analysis ID
- b52f814c0f937d0ea65c0cec659adcf3
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Genor Biotechnology Co., Ltd
Product details
- Intended Use
- This product qualitatively detects human chorionic gonadotropins in human urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1155 Human chorionic gonadotropin testing system
- Import Information
- Domestic;; Contract manufacturing
Dates and status
- Registration Date
- Aug 12, 2019
- Expiry Date
- Oct 26, 2028
About this record
Access comprehensive regulatory information for In vitro reagent for Genor pregnancy test in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b52f814c0f937d0ea65c0cec659adcf3 and manufactured by Longteng Biotechnology Co., Ltd. Xinshi Factory;; Genor Biotechnology Co., Ltd. The authorized representative in Taiwan is Genor Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices